$ECOR
electroCore, Inc. Stock $ecor

$ecor Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024022212 Filed on March 13, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$5.443M	$5.191M	$16.03M
YoY Change	95.79%	102.77%	86.57%
Cost Of Revenue	$888.0K	$1.100M	$2.804M
YoY Change	93.89%	71.88%	73.51%
Gross Profit	$4.555M	$4.091M	$13.23M
YoY Change	96.17%	113.07%	89.59%
Gross Profit Margin	83.69%	78.81%	82.51%
Selling, General & Admin	$8.005M	$6.941M	$27.17M
YoY Change	19.3%	11.79%	11.69%
% of Gross Profit	175.74%	169.67%	205.46%
Research & Development	$399.0K	$1.108M	$5.321M
YoY Change	-77.94%	-31.94%	-3.61%
% of Gross Profit	8.76%	27.08%	40.23%
Depreciation & Amortization	$206.0K	$227.0K	$962.0K
YoY Change	68.85%	53.38%	75.55%
% of Gross Profit	4.52%	5.55%	7.27%
Operating Expenses	$8.404M	$8.049M	$32.50M
YoY Change	-1.35%	2.71%	8.86%
Operating Profit	-$3.849M	-$3.958M	-$19.27M
YoY Change	-37.89%	-33.11%	-15.76%
Interest Expense	$225.0K	$135.0K	$433.0K
YoY Change	10956.51%	-4.93%	10725.0%
% of Operating Profit
Other Income/Expense, Net	$221.0K	-$184.0K	$249.0K
YoY Change	85.71%	18300.0%	-11.39%
Pretax Income	-$3.628M	-$4.007M	-$19.02M
YoY Change	-40.31%	-30.63%	-15.81%
Income Tax	-$122.0K	$25.00K	-$186.0K
% Of Pretax Income
Net Earnings	-$3.506M	-$4.032M	-$18.83M
YoY Change	-40.24%	-30.36%	-15.02%
Net Earnings / Revenue	-64.41%	-77.67%	-117.49%
Basic Earnings Per Share	-$0.53		-$3.42
Diluted Earnings Per Share	-$0.53	-$0.61	-$3.42
COMMON SHARES
Basic Shares Outstanding	6.003M shares	6.002M shares	5.515K shares
Diluted Shares Outstanding	6.617M shares		5.515K shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.849M	$10.33M	$10.33M
YoY Change	-34.09%	-41.67%	-41.67%
Cash & Equivalents	$7.849M	$10.33M	$10.33M
Short-Term Investments
Other Short-Term Assets	$879.0K	$1.086M	$1.086M
YoY Change	13.42%	0.74%	0.74%
Inventory	$2.507M	$2.160M	$2.160M
Prepaid Expenses
Receivables	$475.0K	$717.0K	$717.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$11.71M	$14.29M	$14.29M
YoY Change	-23.83%	-32.49%	-32.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$192.0K	$204.0K	$706.0K
YoY Change	464.71%	308.0%	14.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$448.0K	$495.0K	$1.102M
YoY Change	-49.72%	-36.05%	-62.87%
Total Long-Term Assets	$2.180M	$1.808M	$1.808M
YoY Change	-25.5%	-49.54%	-49.54%
TOTAL ASSETS
Total Short-Term Assets	$11.71M	$14.29M	$14.29M
Total Long-Term Assets	$2.180M	$1.808M	$1.808M
Total Assets	$13.89M	$16.10M	$16.10M
YoY Change	-24.1%	-34.96%	-34.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.322M	$2.163M	$2.163M
YoY Change	16.04%	1.6%	1.6%
Accrued Expenses	$5.412M	$5.871M	$5.443M
YoY Change	43.55%	21.25%	17.53%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.827M	$8.123M	$8.123M
YoY Change	33.84%	15.3%	15.3%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.567M	$537.0K	$537.0K
YoY Change	159.01%	-14.08%	-14.08%
Total Long-Term Liabilities	$1.567M	$537.0K	$537.0K
YoY Change	159.01%	-14.08%	-14.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.827M	$8.123M	$8.123M
Total Long-Term Liabilities	$1.567M	$537.0K	$537.0K
Total Liabilities	$9.394M	$8.660M	$8.660M
YoY Change	45.58%	12.91%	12.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$168.7M	-$165.2M
YoY Change	10.82%	12.87%
Common Stock	$173.2M	$172.7M
YoY Change	5.54%	5.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.496M	$7.442M	$7.442M
YoY Change
Total Liabilities & Shareholders Equity	$13.89M	$16.10M	$16.10M
YoY Change	-24.1%	-34.96%	-34.96%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$3.506M	-$4.032M	-$18.83M
YoY Change	-40.24%	-30.36%	-15.02%
Depreciation, Depletion And Amortization	$206.0K	$227.0K	$962.0K
YoY Change	68.85%	53.38%	75.55%
Cash From Operating Activities	-$2.558M	-$3.123M	-$14.67M
YoY Change	-56.35%	-22.2%	-11.88%
INVESTING ACTIVITIES
Capital Expenditures		$41.00K	$206.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$41.00K	-$206.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$8.144M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-3.000K	$7.487M
YoY Change
NET CHANGE
Cash From Operating Activities	-$2.558M	-3.123M	-$14.67M
Cash From Investing Activities		-41.00K	-$206.0K
Cash From Financing Activities		-3.000K	$7.487M
Net Change In Cash	-$2.482M	-3.164M	-$7.381M
YoY Change	-57.24%	-21.18%	-55.87%
FREE CASH FLOW
Cash From Operating Activities	-$2.558M	-$3.123M	-$14.67M
Capital Expenditures		$41.00K	$206.0K
Free Cash Flow		-$3.164M	-$14.87M
YoY Change			-10.64%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-37000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	307000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	625000	usd
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001560258
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2022Q3	ecor	Period Considered For Calculating Average Adjusted Financial Statement Income PeriodConsideredForCalculatingAverageAdjustedFinancialStatementIncome	P3Y
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38538
CY2023	dei	Entity Registrant Name EntityRegistrantName	electroCore, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-3454976
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	200 Forge Way
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 205
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Rockaway
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07866
CY2023	dei	City Area Code CityAreaCode	(973)
CY2023	dei	Local Phone Number LocalPhoneNumber	290-0097
CY2023	dei	Security12b Title Security12bTitle	Common Stock, Par Value $0.001 Per Share
CY2023	dei	Trading Symbol TradingSymbol	ECOR
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	22358200	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6002628	shares
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum llp
CY2023	dei	Auditor Location AuditorLocation	New York
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10331000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17712000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	250000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	250000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	717000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	401000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2160000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1982000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	836000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	828000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	14294000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	21173000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	607000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	2194000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	204000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	502000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	565000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	495000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	774000	usd
CY2023Q4	us-gaap	Assets Assets	16102000	usd
CY2022Q4	us-gaap	Assets Assets	24756000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2163000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2129000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4842000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	89000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	74000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8123000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7045000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	537000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	8660000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	7670000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	71173	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	71173	shares
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6002628	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6002628	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4744886	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4744886	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	6000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	172704000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	163520000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-165204000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-146370000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-64000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	7442000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17086000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16102000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24756000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16030000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8592000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2804000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1616000	usd
CY2023	us-gaap	Gross Profit GrossProfit	13226000	usd
CY2022	us-gaap	Gross Profit GrossProfit	6976000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5321000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5520000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27174000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24330000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	32495000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	29850000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-19269000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-22874000	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	433000	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	287000	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	184000	usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	6000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	249000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	281000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19020000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22593000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-186000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-431000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18834000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-22162000	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18834000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-22162000	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.42
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.42
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.69
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.69
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5515	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5515	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4729	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4729	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18834000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-22162000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	5000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-82000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	5000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-82000	usd
CY2023	ecor	Preferred Dividend PreferredDividend		usd
CY2022	ecor	Preferred Dividend PreferredDividend		usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18829000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22244000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	36648000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-22162000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-82000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2682000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17086000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18834000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	5000	usd
CY2023	ecor	Stock And Warrants Issued During Period Value StockAndWarrantsIssuedDuringPeriodValue	8144000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	657000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1698000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	7442000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-18834000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-22162000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1698000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	962000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	548000	usd
CY2023	ecor	Increase Decrease In Allowance For Doubtful Accounts IncreaseDecreaseInAllowanceForDoubtfulAccounts	-54000	usd
CY2022	ecor	Increase Decrease In Allowance For Doubtful Accounts IncreaseDecreaseInAllowanceForDoubtfulAccounts		usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	63000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	682000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	196000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	262000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-96000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-296000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-225000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	35000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1191000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1027000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	356000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-73000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-62000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14668000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16645000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	206000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-206000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8144000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	657000	usd
CY2022	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts		usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7487000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-82000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7381000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16727000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17962000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	34689000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10581000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17962000	usd
CY2023	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	211000	usd
CY2022	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	445000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	13000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	6000	usd
CY2023	ecor	Insurancepremium Financing InsurancepremiumFinancing	361000	usd
CY2022	ecor	Insurancepremium Financing InsurancepremiumFinancing	522000	usd
CY2023Q4	ecor	Number Of Wholly Owned Subsidiaries NumberOfWhollyOwnedSubsidiaries	2	subsidiary
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	1
CY2023Q1	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	10
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-15
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin: 0px; text-indent: 0px;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;">(c) Use of Estimates</span></p> <p style="margin: 0px; text-indent: 0px;"><br/></p> <p style="margin: 0px; text-indent: 0px;"><span style="font-size: 10pt; line-height: inherit;"><span style="font-family: 'Times New Roman'; line-height: inherit;">The preparation of financial statements in conformity with U.S.</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> GAAP</span><span style="font-family: 'Times New Roman'; line-height: inherit;"> requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from t<span style="color: #000000; line-height: inherit;">hose estimates. Significant items subject to such estimates and assumptions include trade credits, rebates, co-payment assistance and sales returns, <span style="font-family: ' times new roman'; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px; line-height: inherit;">valuation of inventory</span><span style="font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px; line-height: inherit;">, estimated useful life of licensed products</span><span style="font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px; line-height: inherit;">, income taxes,</span></span><span style="color: #000000; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px; line-height: inherit;"> stock compensation, and contingencies.</span></span></span></p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10331000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	250000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10581000	usd
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	4200000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin: 0px; text-indent: 0px; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;">(f) Concentration of Credit Risk</span></p> <p style="margin: 0px; text-indent: 0px; line-height: 1.2;"><br/></p> <p style="margin: 0px; text-indent: 0px; line-height: 1.2;"><span style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">Cash equivalents are financial instruments that potentially subject the Company to concentration of credit risk. As of <span>December 31, 2023</span>, the Company's cash equivalent securities were largely comprised of money market funds. The Company has established <span style="line-height: inherit;"><span style="line-height: inherit;">guidelines </span></span><span style="line-height: inherit;">relative to diversification and maturities that are designed to help ensure safety and liquidity. These guidelines are periodically reviewed to take advantage of trends in yields and interest rates. <span style="line-height: inherit;">As of <span>December 31, 2023</span><span style="color: #000000; line-height: inherit;">, </span></span><span style="color: #000000; line-height: inherit;"><span style="line-height: inherit;"><span style="line-height: inherit;"><span style="border-left: none; border-right: none; line-height: inherit;">95%</span></span> of </span>the Company’s cas</span>h and cash equivalents were denominated in U.S. dollars. The balance of the Company's cash is denominated in British pound sterling and is subject to foreign exchange risk. <span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: inherit;">The Company’s cash accounts are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000<span style="line-height: inherit;"> </span>per financial institution in the United States, and up to<span style="line-height: inherit;"> </span></span><span style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: inherit;">£<span style="border-left: none; border-right: none; line-height: inherit;">85,000</span></span><span style="color: black; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: inherit;"> by the Financial Services Compensation Scheme (“FSCS”) per financial institution in the United Kingdom. The Company's cash equivalent securities are insured by the Securities Investor Protection Corp. ("SIPC') up to $500,000 per account, with a limit of $250,000 in cash. </span></span></span></p>
CY2023Q4	ecor	Cash Equivalents And Marketable Securities Rate CashEquivalentsAndMarketableSecuritiesRate	0.95	pure
CY2023Q4	ecor	Cash Equivalent Securities Sipc Maximum Insured Amount CashEquivalentSecuritiesSIPCMaximumInsuredAmount	500000	usd
CY2023Q4	ecor	Cash Equivalent Securities Sipc Maximum Cash Limit Of Insured Amount CashEquivalentSecuritiesSIPCMaximumCashLimitOfInsuredAmount	250000	usd
CY2023Q4	us-gaap	Inventory Adjustments InventoryAdjustments	0	usd
CY2023	ecor	Leasehold Improvements Term LeaseholdImprovementsTerm	Lesser of estimated useful life or remaining term of lease
CY2023Q4	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P1Y
CY2023Q4	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	1200000	usd
CY2023	ecor	Amortization Of Cloud Computing Arrangement AmortizationOfCloudComputingArrangement	235000	usd
CY2022	ecor	Amortization Of Cloud Computing Arrangement AmortizationOfCloudComputingArrangement	282000	usd
CY2023	ecor	Licensed Products Policy Text Bolock LicensedProductsPolicyTextBolock	<p style="margin: 0px; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 0px;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"><span style="color: #000000; font-size: 10pt; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-family: 'Times New Roman'; font-style: italic; font-weight: bold; line-height: inherit;">(l) Licensed Products</span></span></p> <p style="margin: 0px; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 0px; line-height: 1.2;"><br/></p> <p style="margin: 0px; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 0px;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"><span style="font-size: 10pt; font-family: 'times new roman', times; color: #000000; line-height: inherit;">The Company licenses a portion of its devices through its cash pay channels. The cost of these licensed devices is capitalized and included in Other Assets in the accompanying Consolidated Balance Sheets at December 31, 2023 and December 31, 2022, and is being recognized as cost of goods sold on the straight-line method over the estimated 12-36 month useful life of the devices. If certain licensed devices are returned and no longer meet quality specifications or the carrying amount of certain licensed devices are no longer deemed to be recoverable, the Company records a charge to cost of goods sold to write down such licensed devices to zero. The net book value of these licensed devices at December 31, 2023 and December 31, 2022 was $494,000 and $538,000, respectively. Changes in the value of these licensed devices in Other Assets is captured on the Statement of Cash Flows with inventories. </span></span></p>
CY2023Q4	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	0	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.601	pure
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	200000	usd
CY2023Q4	ecor	Inventory Noncurrent Raw Materials InventoryNoncurrentRawMaterials	500000	usd
CY2022Q4	ecor	Inventory Noncurrent Raw Materials InventoryNoncurrentRawMaterials	100000	usd
CY2023Q4	ecor	Inventory Noncurrent Work In Process InventoryNoncurrentWorkInProcess	100000	usd
CY2022Q4	ecor	Inventory Noncurrent Work In Process InventoryNoncurrentWorkInProcess	2100000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16030000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8592000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16030000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8592000	usd
CY2023	ecor	Payment Term For Customers PaymentTermForCustomers	P30D
CY2023Q4	ecor	Inventory Raw Materials Current And Noncurrent InventoryRawMaterialsCurrentAndNoncurrent	832000	usd
CY2022Q4	ecor	Inventory Raw Materials Current And Noncurrent InventoryRawMaterialsCurrentAndNoncurrent	944000	usd
CY2023Q4	ecor	Inventory Work In Process Current And Noncurrent InventoryWorkInProcessCurrentAndNoncurrent	1538000	usd
CY2022Q4	ecor	Inventory Work In Process Current And Noncurrent InventoryWorkInProcessCurrentAndNoncurrent	2879000	usd
CY2023Q4	ecor	Inventory Finished Goods Current And Noncurrent InventoryFinishedGoodsCurrentAndNoncurrent	397000	usd
CY2022Q4	ecor	Inventory Finished Goods Current And Noncurrent InventoryFinishedGoodsCurrentAndNoncurrent	353000	usd
CY2023Q4	ecor	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	2767000	usd
CY2022Q4	ecor	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	4176000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	607000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	2194000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1982000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	700000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	700000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	700000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	502000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	565000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	89000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	74000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	537000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	625000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	626000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	699000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y2M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y1M6D
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.138	pure
CY2022Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.138	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	168000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	171000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	161000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	157000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	216000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	873000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	247000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	626000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	282000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	524000	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2352000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2042000	usd
CY2023Q4	ecor	Accrued Legal Fees Litigation Expense Current AccruedLegalFeesLitigationExpenseCurrent	1041000	usd
CY2022Q4	ecor	Accrued Legal Fees Litigation Expense Current AccruedLegalFeesLitigationExpenseCurrent	1001000	usd
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	247000	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	264000	usd
CY2023Q4	ecor	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	655000	usd
CY2022Q4	ecor	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent		usd
CY2023Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	628000	usd
CY2022Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	534000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	272000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	133000	usd
CY2023Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	245000	usd
CY2022Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	152000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	149000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	192000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5871000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4842000	usd
CY2023Q3	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	61800	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	247000	usd
CY2022Q3	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	87900	usd
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-15
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1756000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	632000	shares
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-18713000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-21518000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-307000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1075000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19020000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22593000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-208000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-449000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	22000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	18000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-186000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-431000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-186000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-431000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3500000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	33580000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	29854000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	197000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	257000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	2547000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1720000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	5000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	172000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	165000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	9000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	3000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	10000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	10000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1257000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	422000	usd
CY2023Q4	ecor	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	152000	usd
CY2022Q4	ecor	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	172000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2925000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4744000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	40849000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	37352000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	40564000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	37046000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	285000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	306000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	163000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	167000	usd
CY2023Q4	ecor	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	122000	usd
CY2022Q4	ecor	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	139000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	285000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	306000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.051	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.073	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	-0.028	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	-0.095	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.107	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.002	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.009	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.016	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.022	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.002	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.147	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.185	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.01	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.019	pure
CY2023	ecor	Period For Cumulative Change In Ownership PeriodForCumulativeChangeInOwnership	P3Y
CY2023Q4	ecor	Cumulative Change In Ownership Percentage CumulativeChangeInOwnershipPercentage	0.50	pure
CY2023	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	215000	usd
CY2022Q3	ecor	Percentage Of Corporate Alternative Minimum Tax Rate PercentageOfCorporateAlternativeMinimumTaxRate	0.15	pure
CY2022Q3	ecor	Threshold Of Avergage Adjusted Financial Statement Income For Corporate Altenative Minimum Tax Applicability ThresholdOfAvergageAdjustedFinancialStatementIncomeForCorporateAltenativeMinimumTaxApplicability	1000000000	usd
CY2022Q3	ecor	Excise Tax Rate Percentage ExciseTaxRatePercentage	0.01	pure
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1700000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y6M
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1698000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2682000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	440000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	55.65
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	206000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q4	ecor	Share Based Compensation Arrangement By Share Based Payment Granted ShareBasedCompensationArrangementByShareBasedPaymentGranted		usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q4	ecor	Share Based Compensation Arrangement By Share Based Payment Exercised ShareBasedCompensationArrangementByShareBasedPaymentExercised		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	130000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q4	ecor	Share Based Compensation Arrangement By Share Based Payment Cancelled ShareBasedCompensationArrangementByShareBasedPaymentCancelled		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	516000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	37.46
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y8M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	252000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	67.7
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y6M
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	39000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	1	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.50	pure
CY2023	ecor	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate Of Peer Entities ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRateOfPeerEntities	0.50	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.95
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.2
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.224	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.906	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.041	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.021	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M18D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y9M18D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2020Q3	ecor	Number Of Investors As Defendants NumberOfInvestorsAsDefendants	2	investors

Files In Submission

Name	View Source	Status
0001213900-24-022212-index-headers.html	Edgar Link	pending
0001213900-24-022212-index.html	Edgar Link	pending
0001213900-24-022212.txt	Edgar Link	pending
0001213900-24-022212-xbrl.zip	Edgar Link	pending
ecor-20231231.htm	Edgar Link	pending
ecor-20231231.xsd	Edgar Link	pending
ex211_2.htm	Edgar Link	pending
ex231_3.htm	Edgar Link	pending
ex311_4.htm	Edgar Link	pending
ex312_5.htm	Edgar Link	pending
ex321_6.htm	Edgar Link	pending
ex322_7.htm	Edgar Link	pending
ex41_1.htm	Edgar Link	pending
ex971_8.htm	Edgar Link	pending
ecor-20231231_cal.xml	Edgar Link	unprocessable
ecor-20231231_def.xml	Edgar Link	unprocessable
ecor-20231231_lab.xml	Edgar Link	unprocessable
ecor-20231231_pre.xml	Edgar Link	unprocessable
ecor-20231231_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
img6d1474159917498fa374.jpg	Edgar Link	pending
imgde334d45f9cf43a9a314.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ECOR
electroCore, Inc. Stock $ecor

2024 Q1 Form 10-K Financial Statement

#000121390024022212 Filed on March 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ECOR electroCore, Inc. Stock $ecor

2024 Q1 Form 10-K Financial Statement

#000121390024022212 Filed on March 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ECOR
electroCore, Inc. Stock $ecor